ClinicalTrials.gg
Not yet recruitingNCT07950423temideliriumUpdated Nov 20, 2026

Demonstrating Feasibility of Using a Robot to Deliver a Multicomponent Intervention to Reduce Delirium Occurrence in Hospitalized Elderly Subjects at Risk of Delirium

An interventional study of personalized multicomponent non-pharmacological intervention through an autonomous mobile robot to prevent delirium in Delirium Prevention, sponsored by Vigorous Mind, Inc.. Not yet recruiting at 1 site in United States. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-11-20.

Sponsored by Vigorous Mind, Inc. · Not applicable, Interventional, and Prevention

How we know

Updated Nov 20, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 263 studies in Delirium with a site in United States — 37 open to participants now, 60 under way, 7 of them phase 3. Delirium · United States.

Planned enrollment
137th of 194
30 · median 84
Started
2026
with 13 others
No phase
105 of 263
20 open now
Primary completion
2027-04
later than 31 of 59 live
Registered
263rd of 263
by date

Among the 263 studies in Delirium with a site in United States, this one is the 137th largest by planned enrollment of the 194 interventional ones that give a count, is one of 14 that started in 2026, is one of 105 with no phase, reaches primary completion later than 31 of the 59 other live ones, and was the 263rd registered.

Delirium

935 studies on the registry are indexed under Delirium; 188 are open to participants now.

Browse Delirium studies →

Open to participants now

37 of the 263 studies in Delirium with a site in United States are open now. Recruiting first, the newest first:

32 more — sign in →

All 37 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 124 Delirium studies recruiting now, 96 (77%) set no upper age limit and 8 (6%) stop at 75 or younger; 8 take children under 18; 14 take healthy volunteers.

This study: 65 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 263 studies in Delirium with a site in United States, or all of them as a file.
02

Study summary

This is a feasibility study. 20 non-ICU hospitalized patients at high risk of getting delirium will be consented and screened to receive a personalized multicomponent non-pharmacological intervention through an autonomous navigating robot at the bedside.

03

Conditions studied

  • Delirium Prevention

Browse trials for

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion criteria: High risk of delirium: Agr >80, dementia, High readmission risk score as calculated by EPIC, postoperative

Exclusion Criteria: Patients who screen positive for delirium by CAM Patients who are actively dying Patients who cannot perform the CAM due to language or advanced dementia or level of consciousness

-

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Other
    patients at high risk of delirium who meet the inclusion criteria

    Feasibility study of using an autonomous mobile robot to deliver a personalized multicomponent non-pharmacological intervention to prevent delirium at the bedside

    Other: personalized multicomponent non-pharmacological intervention through an autonomous mobile robot to prevent delirium

Interventions

  • Otherpersonalized multicomponent non-pharmacological intervention through an autonomous mobile robot to prevent delirium

    personalized multicomponent non-pharmacological intervention through an autonomous mobile robot to prevent delirium

06

What researchers measure

Primary outcomes

  1. Robot correctly arrived at the bedside and greeted the patient

    The robot has to navigate to the bedside of each patient at a scheduled time

    Time frame: Two months of feasibility study

  2. Robot correctly arrived at the bedside, oriented the patient and delivered the personalized multicomponent non-pharmacological intervention.

    The robot has to identify the patient, get permission to talk to the patient and then deliver the orientation and engage the patient in a series of activities if the patient agrees.

    Time frame: Two months of the feasibility study

07

Study locations

1 site
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Apr 2027, 5 months later.

Of 222 interventional studies with no phase under Delirium, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 45. This study's planned 5 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 15, 2026
First posted
Nov 20, 2026
StartEst.
Nov 16, 2026
Primary completionEst.
Apr 30, 2027
CompletionEst.
Apr 30, 2027
Last update
Nov 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 20, 2026
Show all 1 update
  1. Nov 20, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07950423
Lead sponsor
Vigorous Mind, Inc.
Responsible party
Sponsor
First posted
Nov 20, 2026
Start date
Nov 16, 2026 (estimated)
Primary completion
Apr 30, 2027 (estimated)
Completion
Apr 30, 2027 (estimated)
Last update
Nov 20, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion